|ITEM METADATA RECORD
|Title: ||Common or distinct INN for biosimilars? Only characteristics of the active substance prior to formulation should be considered|
|Authors: ||Declerck, Paul # ×|
|Issue Date: ||12-Feb-2014 |
|Publisher: ||Generics and Biosimilars Initiative|
|Series Title: ||GaBI - Generics and Biosimilars Initiative Journal vol:3 issue:1 pages:8-8|
|Publication status: ||published|
|KU Leuven publication type: ||IT|
|Appears in Collections:||Therapeutic and Diagnostic Antibodies (+)|
× corresponding author|
# (joint) last author|
|Files in This Item:
There are no files associated with this item.
Request a copy
All items in Lirias are protected by copyright, with all rights reserved.